These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31878861)

  • 1. Petra/Osiris/Molinspiration and Molecular Docking Analyses of 3-Hydroxy-Indolin-2-one Derivatives as Potential Antiviral Agents.
    Hadda TB; Rastija V; AlMalki F; Titi A; Touzani R; Mabkhot YN; Khalid S; Zarrouk A; Siddiqui BS
    Curr Comput Aided Drug Des; 2021; 17(1):123-133. PubMed ID: 31878861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation.
    De Luca L; De Grazia S; Ferro S; Gitto R; Christ F; Debyser Z; Chimirri A
    Eur J Med Chem; 2011 Feb; 46(2):756-64. PubMed ID: 21227550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of novel bioisosteres of beta-diketo acid inhibitors of HIV-1 integrase.
    Sechi M; Sannia L; Carta F; Palomba M; Dallocchio R; Dessì A; Derudas M; Zawahir Z; Neamati N
    Antivir Chem Chemother; 2005; 16(1):41-61. PubMed ID: 15739621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
    Pais GC; Zhang X; Marchand C; Neamati N; Cowansage K; Svarovskaia ES; Pathak VK; Tang Y; Nicklaus M; Pommier Y; Burke TR
    J Med Chem; 2002 Jul; 45(15):3184-94. PubMed ID: 12109903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico evaluation of molecular interactions between macrocyclic inhibitors with the HCV NS3 protease. Docking and identification of antiviral pharmacophore site.
    Lafridi H; Almalki FA; Ben Hadda T; Berredjem M; Kawsar SMA; Alqahtani AM; Esharkawy ER; Lakhrissi B; Zgou H
    J Biomol Struct Dyn; 2023 Apr; 41(6):2260-2273. PubMed ID: 35075979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay.
    Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A
    Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
    Reddy KK; Singh SK
    Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'-
    Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological activity and POM/DFT/docking analyses of annulated pyrano[2,3-d]pyrimidine derivatives: Identification of antibacterial and antitumor pharmacophore sites.
    Bhat AR; Dongre RS; Almalki FA; Berredjem M; Aissaoui M; Touzani R; Hadda TB; Akhter MS
    Bioorg Chem; 2021 Jan; 106():104480. PubMed ID: 33279245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallographic study, biological assessment and POM/Docking studies of pyrazoles-sulfonamide hybrids (PSH): Identification of a combined Antibacterial/Antiviral pharmacophore sites leading to
    Chalkha M; Nakkabi A; Hadda TB; Berredjem M; Moussaoui AE; Bakhouch M; Saadi M; Ammari LE; Almalki FA; Laaroussi H; Jevtovic V; Yazidi ME
    J Mol Struct; 2022 Nov; 1267():133605. PubMed ID: 35782312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors.
    Sirous H; Fassihi A; Brogi S; Campiani G; Christ F; Debyser Z; Gemma S; Butini S; Chemi G; Grillo A; Zabihollahi R; Aghasadeghi MR; Saghaie L; Memarian HR
    Med Chem; 2019; 15(7):755-770. PubMed ID: 30569867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions.
    Maurin C; Bailly F; Cotelle P
    Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit optimization studies of 3-hydroxy-indolin-2-one analogs as potential anti-HIV-1 agents.
    Chander S; Tang CR; Penta A; Wang P; Bhagwat DP; Vanthuyne N; Albalat M; Patel P; Sankpal S; Zheng YT; Sankaranarayanan M
    Bioorg Chem; 2018 Sep; 79():212-222. PubMed ID: 29775947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
    Marchand C; Beutler JA; Wamiru A; Budihas S; Möllmann U; Heinisch L; Mellors JW; Le Grice SF; Pommier Y
    Antimicrob Agents Chemother; 2008 Jan; 52(1):361-4. PubMed ID: 17967911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting HIV-1 integrase with strand transfer inhibitors.
    Li Y; Xuan S; Feng Y; Yan A
    Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.